Eli Lilly
Monsanto deals milk hormone for $300 million
The agribusiness giant Monsanto Co. said it would sell its milk hormone Posilac (rbST, rbGH) to Eli Lilly & Co. for $300 million upfront, plus “additional contingent consideration.” The agreement will expand Lilly’s veterinary operations and enable Monsanto to focus on genetically modified crops. That same day, Lilly’s stock fell 39 cents to $47.41 while Continue Reading
Categories: FDA, Food Labeling, Food Safety, Genetically Modified Organisms, Hormones, rbGH (rbST, Posilac)
Tags: Eli Lilly, Monsanto
Consumers Union is an expert, independent, nonprofit organization whose mission is to work for a fair, just, and safe marketplace for all consumers and to empower consumers to protect themselves.